WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO?
The paper discusses the use of the recommended methotrexate doses for the treatment of rheumatoid arthritis in the randomized clinical comparative trials with biological agents.
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2017-03-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/2347 |
| id |
doaj-b0e1eb40937b4c37969d7c099c6bd232 |
|---|---|
| record_format |
Article |
| spelling |
doaj-b0e1eb40937b4c37969d7c099c6bd2322021-08-02T09:05:50ZrusIMA-PRESS LLCНаучно-практическая ревматология1995-44841995-44922017-03-0155111211410.14412/1995-4484-2017-112-1142208WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO?Yu. V. Muravyev0E. L. Nasonov1V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of Rheumatology Institute of Professional Education, I.M. Sechenov First Moscow State Medical University, Ministry of Health of RussiaThe paper discusses the use of the recommended methotrexate doses for the treatment of rheumatoid arthritis in the randomized clinical comparative trials with biological agents.https://rsp.mediar-press.net/rsp/article/view/2347rheumatoid arthritismethotrexaterandomized clinical trialsbiological agents |
| collection |
DOAJ |
| language |
Russian |
| format |
Article |
| sources |
DOAJ |
| author |
Yu. V. Muravyev E. L. Nasonov |
| spellingShingle |
Yu. V. Muravyev E. L. Nasonov WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO? Научно-практическая ревматология rheumatoid arthritis methotrexate randomized clinical trials biological agents |
| author_facet |
Yu. V. Muravyev E. L. Nasonov |
| author_sort |
Yu. V. Muravyev |
| title |
WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO? |
| title_short |
WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO? |
| title_full |
WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO? |
| title_fullStr |
WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO? |
| title_full_unstemmed |
WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO? |
| title_sort |
why are the recommended methotrexate doses not used for the treatment of rheumatoid arthritis: who is guilty and what to do? |
| publisher |
IMA-PRESS LLC |
| series |
Научно-практическая ревматология |
| issn |
1995-4484 1995-4492 |
| publishDate |
2017-03-01 |
| description |
The paper discusses the use of the recommended methotrexate doses for the treatment of rheumatoid arthritis in the randomized clinical comparative trials with biological agents. |
| topic |
rheumatoid arthritis methotrexate randomized clinical trials biological agents |
| url |
https://rsp.mediar-press.net/rsp/article/view/2347 |
| work_keys_str_mv |
AT yuvmuravyev whyaretherecommendedmethotrexatedosesnotusedforthetreatmentofrheumatoidarthritiswhoisguiltyandwhattodo AT elnasonov whyaretherecommendedmethotrexatedosesnotusedforthetreatmentofrheumatoidarthritiswhoisguiltyandwhattodo |
| _version_ |
1721235668902871040 |